http://www.seqidno.com/ <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-ip-services-inc-turns-15 <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology <br type="_moz" /> http://www.seqidno.com/resources/blog/harbor-consulting-participates-in-the-2010-jimmy-fund-fantasy-day-at-fenway <br type="_moz" /> http://www.seqidno.com/resources/blog/federal-circuit-court-affirms-itc-ruling-on-behalf-of-global-biochem-technology Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine Global BioChem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated cornbased biochemical manufacturer in Asia, have prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). http://www.seqidno.com/resources/blog/judge-rules-that-chinese-biotechnlogy-company-gbt-may-continue-to-import-lysine <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag <p>Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG</p> <ul> <li>Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases</li> <li>Acquisition establishes sustainable platform for ongoing biologics development</li> <li>Deal builds on other recent transactions to expand breadth and depth of Alcon's development opportunities in long term eye care</li> <li>ESBATech shareholders retain rights to nonophthalmic technology and products</li> </ul> http://www.seqidno.com/resources/blog/alcon-to-acquire-swiss-biotechnology-firm-esbatech-ag